Omiganan vs Ramoplanin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Omiganan (CLS001, MBI-226) is a synthetic analog of indolicidin, a bovine neutrophil AMP. It was developed for topical antimicrobial applications including acne vulgaris, catheter-site infection prevention, and rosacea....
Calculate Omiganan dose →Ramoplanin is a glycodepsipeptide antibiotic produced by Actinoplanes sp. ATCC 33076 with potent activity against gram-positive bacteria....
Calculate Ramoplanin dose →| Parameter | Omiganan | Ramoplanin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Phase 3 (Completed) | Phase 3 (Discontinued) |
| Half-Life | Hours (topical) | Short (gut lumen) |
| Typical Dose | 1-3% gel | 200 mg twice daily |
| Frequency | Twice daily | Twice daily |
| Route | Topical gel/cream | Oral (non-absorbed) |
| FDA Status | Not approved | Not approved (Phase 3 discontinued) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.